Shanghai Model Organisms Center, Inc. (SHA:688265)

SHA:688265 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	432.55	421.02	381.24	366.55	302.97	275.27
Revenue Growth	11.86%	10.44%	4.01%	20.99%	10.06%	40.31%
Gross Profit Gross Profit Growth	226.14	215.53	173.15	152.78	124.5	165.8
Operating Income Operating Income Growth	10.18	4.45	-23.31	-47.04	-43.43	58.17
Net Income Net Income Growth	33.09	31.44	6.5	-20.58	-5.4	60.86
Earnings Per Share EPS Growth	0.49	0.42	0.08	-0.26	-0.07	1.04
EPS Growth	128.93%	425.00%	-	-	-	33.33%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Standardized Model Standardized Model Growth	203.02	164.77
Custom Model Custom Model Growth	33.32	33.91
Drug Efficacy Evaluation and Phenotypic Analysis Drug Efficacy Evaluation and Phenotypic Analysis Growth	58.87	53.2
Model Breeding Model Breeding Growth	80.04	90.06
Feeding Service Feeding Service Growth	36.35	29.97
Other Model Biotechnology Services Other Model Biotechnology Services Growth	6.69	6.58
Total Total Growth	418.29	378.49

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	931.99	1,034	1,011	1,025	1,131	1,676
Total Debt Total Debt Growth	59	56.81	77.42	94.76	120.95	26.04
Net Cash (Debt) Net Cash Growth	872.99	976.73	933.68	930.13	1,010	1,650
Net Cash Growth	-4.03%	4.61%	0.38%	-7.89%	-38.81%	1065.35%
Net Cash Per Share Net Cash Per Share Growth	12.88	13.05	11.50	11.75	13.09	28.20

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	88.29	96.92	71.56	20.08	18.89	111.46
Capital Expenditures CapEx Growth	-65.15	-45.61	-25.24	-124.3	-270.26	-52.36
Free Cash Flow Free Cash Flow Growth	23.14	51.31	46.33	-104.22	-251.37	59.1
Free Cash Flow Growth	-54.15%	10.75%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	52.28%	51.19%	45.42%	41.68%	41.09%	60.23%
Operating Margin	2.35%	1.06%	-6.11%	-12.83%	-14.34%	21.13%
Pretax Margin	7.35%	6.91%	0.72%	-8.16%	-4.86%	25.09%
Profit Margin	7.65%	7.47%	1.70%	-5.62%	-1.78%	22.11%
FCF Margin	5.35%	12.19%	12.15%	-28.43%	-82.97%	21.47%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.125	0.125	-	0.130	-	0.257
Dividend Per Share Growth	0%	-	-	-	-	-
Dividend Yield	0.37%	0.31%	-	0.34%	-	0.37%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	73.08	98.65	269.15	-	-	89.74
Forward PE	-	32.22	32.22	32.22	41.88	-
P/FCF Ratio	116.58	60.44	37.74	-	-	92.41
PS Ratio	6.24	7.37	4.59	8.18	12.61	19.84

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error